1 Trademark Results found for "YAVE*"

Also try searching for:

*AVE

Mark	Details	Status	Class/Description
	YAVEMBO Camurus AB 2199281 27 Apr 2022	ADVERTISED on 25 Dec 2024	Pharmaceutical preparations for injection for the treatment of endocri... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations for injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Pharmaceutical preparations for subcutaneous injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for subcutaneous injection for the treatment of tumours; pharmaceutical preparations for subcutaneous injection for the treatment of carcinoid tumours; pharmaceutical preparations for subcutaneous injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for subcutaneous injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for subcutaneous injection for gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of esophageal bleeding; pharmaceutical preparations for subcutaneous injection for metabolic disorders; pharmaceutical preparations for subcutaneous injection for the treatment of acromegaly; pharmaceutical preparations for subcutaneous injection for the treatment of polycystic liver disease; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for subcutaneous injection intended to block growth hormone; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for the treatment of neuroendocrine tumours; pharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of esophageal bleeding; pharmaceutical preparations for metabolic disorders; pharmaceutical preparations for the treatment of acromegaly; pharmaceutical preparations for the treatment of polycystic liver disease; pharmaceutical preparations for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for the treatment of respiratory distress syndrome; pharmaceutical preparations for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations intended to block growth hormone Class 010 Class 010 Medical Instrument Products Autoinjectors for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; autoinjectors for administration of pharmaceuticals for the treatment of tumours; autoinjectors for administration of pharmaceuticals for the treatment of carcinoid tumours; autoinjectors for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; autoinjectors for administration of pharmaceuticals for the treatment of neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; autoinjectors for administration of pharmaceuticals for gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of esophageal bleeding; autoinjectors for administration of pharmaceuticals for metabolic disorders; autoinjectors for administration of pharmaceuticals for the treatment of acromegaly; autoinjectors for administration of pharmaceuticals for the treatment of polycystic liver disease; autoinjectors for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; autoinjectors for administration of pharmaceuticals for the treatment of respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; autoinjectors for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; pens for administration of pharmaceuticals for the treatment of tumours; pens for administration of pharmaceuticals for the treatment of carcinoid tumours; pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of esophageal bleeding; pens for administration of pharmaceuticals for metabolic disorders; pens for administration of pharmaceuticals for the treatment of acromegaly; pens for administration of pharmaceuticals for the treatment of polycystic liver disease; pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; pens for administration of pharmaceuticals intended to block growth hormone; devices for subcutaneous administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; pens for subcutaneous administration of pharmaceuticals; pens for parenteral administration of pharmaceuticals; pens for injection of pharmaceutical depots; pens for subcutaneous injection of pharmaceutical depot; pens for parenteral injection of pharmaceutical depot; pens for injection of injection fluids; pens for injection of injection depot; pens for injections; pens for medical uses

ADVERTISED

on 25 Dec 2024

YAVEMBO

Camurus AB

2199281 · 27 Apr 2022

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for injection for the treatment of tumours; pharmaceutical preparations for injection for the treatment of carcinoid tumours; pharmaceutical preparations for injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for injection for gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for injection for the treatment of esophageal bleeding; pharmaceutical preparations for injection for metabolic disorders; pharmaceutical preparations for injection for the treatment of acromegaly; pharmaceutical preparations for injection for the treatment of polycystic liver disease; pharmaceutical preparations for injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for injection intended to block growth hormone; Pharmaceutical preparations for subcutaneous injection for the treatment of endocrine diseases and disorders; pharmaceutical preparations for subcutaneous injection for the treatment of tumours; pharmaceutical preparations for subcutaneous injection for the treatment of carcinoid tumours; pharmaceutical preparations for subcutaneous injection comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for subcutaneous injection for the treatment of neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for subcutaneous injection for gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for subcutaneous injection for the treatment of esophageal bleeding; pharmaceutical preparations for subcutaneous injection for metabolic disorders; pharmaceutical preparations for subcutaneous injection for the treatment of acromegaly; pharmaceutical preparations for subcutaneous injection for the treatment of polycystic liver disease; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for subcutaneous injection for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations for subcutaneous injection intended to block growth hormone; pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of carcinoid tumours; pharmaceutical preparations comprising peptides for hormonal treatment and tumour treatment; pharmaceutical preparations for the treatment of neuroendocrine tumours; pharmaceutical preparations for the treatment of gastro-enteropancreatic neuroendocrine tumours; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for the treatment of esophageal bleeding; pharmaceutical preparations for metabolic disorders; pharmaceutical preparations for the treatment of acromegaly; pharmaceutical preparations for the treatment of polycystic liver disease; pharmaceutical preparations for the treatment of respiratory diseases or syndrome; pharmaceutical preparations for the treatment of respiratory distress syndrome; pharmaceutical preparations for the treatment of acute respiratory distress syndrome; pharmaceutical preparations for the treatment of disorders of the autonomic nervous system; pharmaceutical preparations intended to block growth hormone

010

Class 010

Medical Instrument Products

Autoinjectors for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; autoinjectors for administration of pharmaceuticals for the treatment of tumours; autoinjectors for administration of pharmaceuticals for the treatment of carcinoid tumours; autoinjectors for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; autoinjectors for administration of pharmaceuticals for the treatment of neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; autoinjectors for administration of pharmaceuticals for gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; autoinjectors for administration of pharmaceuticals for the treatment of esophageal bleeding; autoinjectors for administration of pharmaceuticals for metabolic disorders; autoinjectors for administration of pharmaceuticals for the treatment of acromegaly; autoinjectors for administration of pharmaceuticals for the treatment of polycystic liver disease; autoinjectors for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; autoinjectors for administration of pharmaceuticals for the treatment of respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; autoinjectors for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; autoinjectors for administration of pharmaceuticals intended to block growth hormone; syringes for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; syringes for administration of pharmaceuticals for the treatment of tumours; syringes for administration of pharmaceuticals for the treatment of carcinoid tumours; syringes for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; syringes for administration of pharmaceuticals for the treatment of neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; syringes for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; syringes for administration of pharmaceuticals for gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; syringes for administration of pharmaceuticals for the treatment of esophageal bleeding; syringes for administration of pharmaceuticals for metabolic disorders; syringes for administration of pharmaceuticals for the treatment of acromegaly; syringes for administration of pharmaceuticals for the treatment of polycystic liver disease; syringes for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; syringes for administration of pharmaceuticals for the treatment of respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; syringes for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; syringes for administration of pharmaceuticals intended to block growth hormone; pens for administration of pharmaceuticals for the treatment of endocrine diseases and disorders; pens for administration of pharmaceuticals for the treatment of tumours; pens for administration of pharmaceuticals for the treatment of carcinoid tumours; pens for administration of pharmaceuticals comprising peptides for hormonal treatment and tumour treatment; pens for administration of pharmaceuticals for the treatment of neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastro-enteropancreatic neuroendocrine tumours; pens for administration of pharmaceuticals for the treatment of gastrointestinal diseases and disorders; pens for administration of pharmaceuticals for gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of gastrointestinal bleeding disorders; pens for administration of pharmaceuticals for the treatment of esophageal bleeding; pens for administration of pharmaceuticals for metabolic disorders; pens for administration of pharmaceuticals for the treatment of acromegaly; pens for administration of pharmaceuticals for the treatment of polycystic liver disease; pens for administration of pharmaceuticals for the treatment of respiratory diseases or syndrome; pens for administration of pharmaceuticals for the treatment of respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of acute respiratory distress syndrome; pens for administration of pharmaceuticals for the treatment of disorders of the autonomic nervous system; pens for administration of pharmaceuticals intended to block growth hormone; devices for subcutaneous administration of pharmaceuticals; syringes for subcutaneous administration of pharmaceuticals; syringes for parenteral administration of pharmaceuticals; syringes for injection of pharmaceutical depots; syringes for subcutaneous injection of pharmaceutical depot; syringes for parenteral injection of pharmaceutical depot; syringes for injection of injection fluids; syringes for injection of injection depot; syringes for injections; syringes for medical uses; pens for subcutaneous administration of pharmaceuticals; pens for parenteral administration of pharmaceuticals; pens for injection of pharmaceutical depots; pens for subcutaneous injection of pharmaceutical depot; pens for parenteral injection of pharmaceutical depot; pens for injection of injection fluids; pens for injection of injection depot; pens for injections; pens for medical uses

Pharmaceutical preparations for injection for the treatment of endocri...

Owners

Camurus ab (1)

Categories

Class 5 (1)

Class 10 (1)

Correspondents

Mccarthy tetrault llp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo trademark

Trademark Name

Country Selected

Canada

$599 / 1 class + gov fee

United States

$99 / 1 class + gov fee

Canada

$599 / 1 class + gov fee

Mexico

$499 / 1 class + gov fee

European Union

$700 / 1 class + gov fee

China

$499 / 1 class + gov fee

South Korea

$699 / 1 class + gov fee

Japan

$799 / 1 class + gov fee

India

$99 / 1 class + gov fee

United Kingdom

$499 / 1 class + gov fee

Australia

$299 / 1 class + gov fee

Israel

$699 / 1 class + gov fee

United Arab Emirates

$699 / 1 class + gov fee

New Zealand

$699 / 1 class + gov fee

Brazil

$499 / 1 class + gov fee

Taiwan

$799 / 1 class + gov fee

Ukraine

$799 / 1 class + gov fee

Indonesia

$699 / 1 class + gov fee

South Africa

$499 / 1 class + gov fee

Singapore

$799 / 1 class + gov fee

Saudi Arabia

$799 / 1 class + gov fee

Afghanistan

$799 / 1 class + gov fee

Algeria

$799 / 1 class + gov fee

Argentina

$399 / 1 class + gov fee

Austria

$899 / 1 class + gov fee

Bahrain

$699 / 1 class + gov fee

Bangladesh

$599 / 1 class + gov fee

Benelux

$999 / 1 class + gov fee

Bhutan

$899 / 1 class + gov fee

Bolivia

$799 / 1 class + gov fee

Botswana

$1299 / 1 class + gov fee

British Virgin Islands

$1199 / 1 class + gov fee

Bulgaria

$799 / 1 class + gov fee

Cambodia

$799 / 1 class + gov fee

Chile

$499 / 1 class + gov fee

Colombia

$699 / 1 class + gov fee

Congo

$1199 / 1 class + gov fee

Costa Rica

$899 / 1 class + gov fee

Croatia

$899 / 1 class + gov fee

Cyprus

$999 / 1 class + gov fee

Czech Republic

$899 / 1 class + gov fee

Denmark

$799 / 1 class + gov fee

Dominican Republic

$899 / 1 class + gov fee

Ecuador

$799 / 1 class + gov fee

Egypt

$699 / 1 class + gov fee

El Salvador

$799 / 1 class + gov fee

Ethiopia

$1099 / 1 class + gov fee

France

$899 / 1 class + gov fee

Gaza

$799 / 1 class + gov fee

Germany

$899 / 1 class + gov fee

Greece

$799 / 1 class + gov fee

Guatemala

$899 / 1 class + gov fee

Haiti

$899 / 1 class + gov fee

Honduras

$899 / 1 class + gov fee

Hong Kong (SAR)

$899 / 1 class + gov fee

Hungary

$1099 / 1 class + gov fee

Iraq

$1499 / 1 class + gov fee

Italy

$899 / 1 class + gov fee

Jordan

$799 / 1 class + gov fee

Kazakhstan

$799 / 1 class + gov fee

Kenya

$899 / 1 class + gov fee

Kuwait

$799 / 1 class + gov fee

Laos

$699 / 1 class + gov fee

Lebanon

$999 / 1 class + gov fee

Lesotho

$1199 / 1 class + gov fee

Libya

$899 / 1 class + gov fee

Madrid Protocol (WIPO)

$1999 / 1 class + gov fee

Malawi

$1099 / 1 class + gov fee

Malaysia

$699 / 1 class + gov fee

Maldives

$999 / 1 class + gov fee

Morocco

$999 / 1 class + gov fee

Mozambique

$899 / 1 class + gov fee

Myanmar

$799 / 1 class + gov fee

Namibia

$799 / 1 class + gov fee

Nepal

$699 / 1 class + gov fee

Nicaragua

$899 / 1 class + gov fee

Norway

$899 / 1 class + gov fee

Oman

$1099 / 1 class + gov fee

Pakistan

$799 / 1 class + gov fee

Panama

$899 / 1 class + gov fee

Paraguay

$899 / 1 class + gov fee

Peru

$799 / 1 class + gov fee

Philippines

$899 / 1 class + gov fee

Poland

$499 / 1 class + gov fee

Portugal

$899 / 1 class + gov fee

Puerto Rico

$899 / 1 class + gov fee

Qatar

$799 / 1 class + gov fee

Romania

$899 / 1 class + gov fee

Serbia

$899 / 1 class + gov fee

Slovakia

$899 / 1 class + gov fee

Spain

$899 / 1 class + gov fee

Sri Lanka

$699 / 1 class + gov fee

Swaziland

$1299 / 1 class + gov fee

Sweden

$799 / 1 class + gov fee

Switzerland

$899 / 1 class + gov fee

Thailand

$799 / 1 class + gov fee

Tunisia

$899 / 1 class + gov fee

Turkey

$799 / 1 class + gov fee

Uganda

$699 / 1 class + gov fee

United Republic of Tanzania

$699 / 1 class + gov fee

Uruguay

$799 / 1 class + gov fee

Venezuela

$899 / 1 class + gov fee

Vietnam

$799 / 1 class + gov fee

West Bank, Palestine

$799 / 1 class + gov fee

Yemen

$1699 / 1 class + gov fee

Albania

$899 / 1 class + gov fee

Andorra

$899 / 1 class + gov fee

Angola

$1299 / 1 class + gov fee

Antigua and Barbuda

$1299 / 1 class + gov fee

Armenia

$799 / 1 class + gov fee

Azerbaijan

$799 / 1 class + gov fee

Bahamas

$1399 / 1 class + gov fee

Barbados

$1299 / 1 class + gov fee

Belgium

$999 / 1 class + gov fee

Belize

$1299 / 1 class + gov fee

Benin

$799 / 1 class + gov fee

Bosnia and Herzegovina

$999 / 1 class + gov fee

Brunei

$1299 / 1 class + gov fee

Burkina Faso

$799 / 1 class + gov fee

Burundi

$1199 / 1 class + gov fee

Cabo Verde

$899 / 1 class + gov fee

Cameroon

$799 / 1 class + gov fee

Central African Republic (CAR)

$799 / 1 class + gov fee

Chad

$799 / 1 class + gov fee

Comoros

$799 / 1 class + gov fee

Cote d'Ivoire

$799 / 1 class + gov fee

Czechia

$999 / 1 class + gov fee

Djibouti

$1199 / 1 class + gov fee

Dominica

$1299 / 1 class + gov fee

Equatorial Guinea

$799 / 1 class + gov fee

Eritrea

$999 / 1 class + gov fee

Estonia

$1299 / 1 class + gov fee

Eswatini

$1299 / 1 class + gov fee

Fiji

$899 / 1 class + gov fee

Finland

$699 / 1 class + gov fee

Gabon

$799 / 1 class + gov fee

Gambia

$899 / 1 class + gov fee

Georgia

$799 / 1 class + gov fee

Ghana

$999 / 1 class + gov fee

Grenada

$1299 / 1 class + gov fee

Guinea

$799 / 1 class + gov fee

Guinea-Bissau

$799 / 1 class + gov fee

Guyana

$1299 / 1 class + gov fee

Iceland

$1299 / 1 class + gov fee

Ireland

$899 / 1 class + gov fee

Jamaica

$1199 / 1 class + gov fee

Kiribati

$999 / 1 class + gov fee

Kosovo

$899 / 1 class + gov fee

Kyrgyzstan

$899 / 1 class + gov fee

Latvia

$699 / 1 class + gov fee

Liberia

$999 / 1 class + gov fee

Liechtenstein

$999 / 1 class + gov fee

Lithuania

$699 / 1 class + gov fee

Luxembourg

$999 / 1 class + gov fee

Madagascar

$999 / 1 class + gov fee

Mali

$799 / 1 class + gov fee

Malta

$599 / 1 class + gov fee

Marshall Islands

$999 / 1 class + gov fee

Mauritania

$799 / 1 class + gov fee

Mauritius

$899 / 1 class + gov fee

Micronesia

$999 / 1 class + gov fee

Moldova

$999 / 1 class + gov fee

Monaco

$1399 / 1 class + gov fee

Mongolia

$599 / 1 class + gov fee

Montenegro

$899 / 1 class + gov fee

Nauru

$999 / 1 class + gov fee

Netherlands

$999 / 1 class + gov fee

Niger

$799 / 1 class + gov fee

Nigeria

$399 / 1 class + gov fee

North Macedonia

$899 / 1 class + gov fee

Palau

$999 / 1 class + gov fee

Palestine

$999 / 1 class + gov fee

Papua New Guinea

$799 / 1 class + gov fee

Rwanda

$999 / 1 class + gov fee

Saint Kitts and Nevis

$1299 / 1 class + gov fee

Saint Lucia

$1299 / 1 class + gov fee

Saint Vincent and the Grenadines

$1299 / 1 class + gov fee

Samoa

$1199 / 1 class + gov fee

San Marino

$999 / 1 class + gov fee

Sao Tome and Principe

$999 / 1 class + gov fee

Senegal

$799 / 1 class + gov fee

Seychelles

$999 / 1 class + gov fee

Sierra Leone

$999 / 1 class + gov fee

Slovenia

$899 / 1 class + gov fee

Solomon Islands

$999 / 1 class + gov fee

Somalia

$999 / 1 class + gov fee

South Sudan

$999 / 1 class + gov fee

Suriname

$1599 / 1 class + gov fee

Tajikistan

$799 / 1 class + gov fee

Tanzania

$699 / 1 class + gov fee

Timor-Leste

$999 / 1 class + gov fee

Togo

$799 / 1 class + gov fee

Tonga

$1299 / 1 class + gov fee

Trinidad and Tobago

$1399 / 1 class + gov fee

Turkmenistan

$799 / 1 class + gov fee

Tuvalu

$999 / 1 class + gov fee

Uzbekistan

$699 / 1 class + gov fee

Vanuatu

$1199 / 1 class + gov fee

Zambia

$899 / 1 class + gov fee

Zimbabwe

$899 / 1 class + gov fee

OAPI

$899 / 1 class + gov fee

ARIPO

$999 / 1 class + gov fee

End of search results

Page 1 of 1